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APCs such as macrophages are important for in-
nate immune defense and for the generation and 
regulation of adaptive immunity against various 
pathogens. Activated macrophages produce pro-
inflammatory cytokines, including IL-6, IL-12, 
and TNF-, which activate T cells and induce 
their differentiation. It has been demonstrated 
that IL-6 combined with TGF- participates in 
the differentiation of naive T cells into IL-17–
producing T helper (Th17) cells (Bettelli et al., 
2006). More recently, our group and others 
demonstrated  that  Aryl  hydrocarbon  receptor 
(Ahr), also known as dioxin receptor, is induced 
by TGF- plus IL-6 in naive T cells and partici-
pates in the differentiation of Th17 cells (Kimura 
et al., 2008; Quintana et al., 2008; Veldhoen   
et al., 2008). We proved that Ahr participates in 
Th17 cell development through regulating acti-
vation of signal-transducer-and-activator-of-
transcription 1 (Stat1), which suppresses Th17 
cell  differentiation  (Stumhofer  et  al.  2006; 
Kimura et al., 2008).
Ahr is a ligand-activated transcription fac-
tor that belongs to the basic-helix-loop-helix-
PER-ARNT-SIM  family  (Burbach  et  al., 
1992; Ema et al., 1992; Fujii-Kuriyama et al., 
1994). Upon binding with a ligand, Ahr un-
dergoes a conformation change, translocates to 
the nucleus, and dimerizes with the Ahr nu-
clear translocator (Arnt). Within the nucleus, 
the Ahr/Arnt heterodimer binds to a specific 
sequence, designated a xenobiotic responsive 
element, which causes a variety of toxicologi-
cal effects (Dragan and Schrenk, 2000; Ohtake 
et al., 2003; Puga et al., 2005). In immune   
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Toll-like receptor (TLR) signals perform a crucial role in innate immune responses to patho-
gens. In this study, we found that the aryl hydrocarbon receptor (Ahr) negatively regulates 
inflammatory responses mediated by lipopolysaccharide (LPS) in macrophages. Ahr was 
induced in macrophages stimulated by LPS, but not by transforming growth factor (TGF)- 
plus interleukin (IL)-6, which can induce Ahr in naive T cells. The production of IL-6 and 
tumor necrosis factor (TNF)- by LPS was significantly elevated in Ahr-deficient macro-
phages compared with that in wild-type (WT) cells. Ahr-deficient mice were more highly 
sensitive to LPS-induced lethal shock than WT mice. Signal transducer and activator of 
transcription 1 (Stat1) deficiency, as well as Ahr deficiency, augmented LPS-induced IL-6 
production. We found that Ahr forms a complex with Stat1 and nuclear factor-kappa B 
(NF-B) in macrophages stimulated by LPS, which leads to inhibition of the promoter 
activity of IL-6. Ahr thus plays an essential role in the negative regulation of the LPS 
signaling pathway through interaction with Stat1.
© 2009 Kimura et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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participates  in  the  induction  of  Th17  cell  differentiation 
(Kimura et al., 2008; Quintana et al., 2008; Veldhoen et al., 
2008). In this study, we used Western blot analysis to investi-
gate Ahr expression in peritoneal macrophages stimulated by 
LPS, CpG-oligodeoxynucleotides (ODNs), and TGF- plus 
IL-6. Ahr was expressed in peritoneal macrophages stimu-
lated by LPS and CpG-ODN, but not by TGF- plus IL-6 
(Fig. 1 A), indicating that Ahr is induced by TLR signaling in 
those cells and that its expression pattern in macrophages and 
T cells is different. We next used Ahr KO peritoneal macro-
phages to examine whether Ahr affects LPS-induced proin-
flammatory cytokine production. As shown in Fig. 1 B, the 
levels of IL-6, TNF-, and IL-12p40 were significantly ele-
vated by LPS in Ahr KO peritoneal macrophages compared 
with those in WT cells. Next, we used a retroviral system to 
investigate whether Ahr reconstitution could reverse the 
phenotype in Ahr KO peritoneal macrophages and found 
that infection with Ahr in Ahr-deficient cells restored the 
overproduction of IL-6 (Fig. S1 A). We also examined TLR4 
expression in WT and Ahr KO peritoneal macrophages, 
which showed the same pattern (unpublished data), indicat-
ing  that  the  LPS  signal  is  normally  transmitted  from  the 
plasma membrane to the cytoplasm between WT and Ahr 
KO cells. To examine the effect of Ahr on LPS signaling, we 
established a mouse macrophage-like cell line (RAW cells) 
that constitutively expressed Ahr (RAW/Ahr). With RAW/
Neo cells functioning as control, RAW/Ahr cells were 
treated with LPS, and LPS-induced production of proinflam-
matory cytokines was examined by means of ELISA. It was 
found that IL-6 and IL-12p40 production by LPS was inhib-
ited in Ahr-overexpressing RAW cells compared with that in 
RAW/Neo cells (Fig. 1 C).
It has been recently reported that Ahr agonists in culture 
medium are important for Th17 cell differentiation, in which 
Iscove’s modified Dulbecco’s medium (IMDM), a medium 
that is richer in amino acids that can give rise to Ahr agonists, 
enhances Th17 cell development more than RPMI medium 
(Veldhoen et al., 2009). We therefore tested whether IMDM 
affects increased LPS-induced production of proinflamma-
tory cytokines in WT- and Ahr-deficient macrophages. Al-
though IMDM suppressed LPS-induced IL-6 production in 
WT peritoneal macrophages when compared with RPMI 
medium, its production was inhibited at the same rate as in 
Ahr KO cells (Fig. S1 B). These results indicate that natural 
ligands for Ahr in this culture medium do not affect the regu-
lation of LPS signaling by Ahr.
Because it is known that macrophages produce an anti-
inflammatory cytokine, IL-10, to control the overproduction 
of inflammatory cytokines (Moore et al., 2001), we com-
pared LPS-induced IL-10 production in WT and Ahr KO 
peritoneal macrophages. In contrast to proinflammatory cy-
tokine production, LPS-induced IL-10 production was in-
hibited in Ahr KO peritoneal macrophages compared with 
that in WT cells (Fig. 1 D). These results demonstrate that 
Ahr has an antiinflammatory function in macrophages under 
the LPS–TLR4 signaling pathway. Because hypoproduction 
responses, Ahr activated by ligands such as 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin  regulates  the  generation  of  regulatory   
T cells and modulates Th1/Th2 balance (Funatake et al., 2005; 
Negishi et al., 2005). Although it has been established that 
Ahr performs an important role in immune regulation as well 
as in toxic responses, it remains unclear how Ahr modulates 
immune responses in individual immune cell populations. 
Ahr-deficient (KO) mice all die within 5 wk of birth under 
conventional conditions where environmental pathogens are 
common, in contrast to their survival in a specific pathogen–
free state, which led us to hypothesize that Ahr also may play 
an essential role in innate immune signaling in macrophages.
The Toll-like receptor (TLR) family is a diverse group of 
transmembrane receptors that recognize microbial compo-
nents. TLRs are expressed mainly on APCs such as macro-
phages and DCs and recognition of microbial products by 
TLRs leads to generation of a variety of signal transduction 
pathways that elicit rapid inflammatory reactions (Akira and 
Takeda, 2004). LPS is the principal active agent in the patho-
genesis of endotoxin shock, which is triggered by the inter-
action of LPS with TLR4 and leads to the production of 
cytokines and other inflammatory mediators, including IL-1, 
IL-6, TNF-, IL-12 and IFNs (Beutler and Rietschel, 2003). 
TLR4 signaling can occur via two independent pathways. 
One depends on myeloid differentiation factor 88 (MyD88), 
which results in the activation of NF-B. This MyD88-
  dependent pathway is critical for the production of IL-6 and 
TNF-. The other pathway is a TIR domain–containing 
adaptor that induces an IFN- (TRIF)–dependent pathway, 
which in turn induces IFN- via IFN regulatory factor-3 
(Fitzgerald et al., 2003). A splice variant of MyD88 (MyD88s) 
inhibits TLR pathways by its failure to recruit IRAK4, while 
TGF- also inhibits the MyD88-dependent pathway for 
LPS–TLR4 signaling (Burns et al., 2003; Naiki et al., 2005). 
We also reported that suppressor of cytokine signaling 1 
(SOCS-1)  negatively  regulates  the  LPS  signal  pathway   
(Nakagawa et al., 2002; Kimura et al., 2005). Thus, while it 
has been demonstrated that various regulatory systems are   
involved in TLR signaling, the mechanisms underlying   
the  negative  regulation  in  TLRs  signaling  have  not  been   
fully elucidated.
This study deals with a novel regulatory system for TLR 
signaling in which Ahr negatively regulates the inflammatory 
responses by LPS. We demonstrate that LPS-induced pro-
inflammatory cytokines are augmented in Ahr-deficient 
macrophages  compared  with  those  in  WT  cells,  and  that 
Ahr-deficient mice are more susceptible to endotoxin shock 
induced by LPS. We also provide evidence that Ahr interacts 
with Stat1 and NF-B and that the Ahr–Stat1 complex con-
trols NF-B-dependent proinflammatory responses by LPS.
RESULTS
Increased LPS-induced production of proinflammatory 
cytokines in Ahr deficient macrophages
Our group and others previously reported that Ahr is in-
duced in naive T cells stimulated by TGF- plus IL-6, which JEM VOL. 206, August 31, 2009 
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similarly to those in WT mice until 2 h after LPS challenge, 
serum IL-6 in Ahr KO mice maintained the same level for 
2–12 h and then increased again (Fig. 2 B). On the other 
hand, serum TNF- levels in Ahr KO mice were signifi-
cantly higher than in WT mice 2 h after LPS administration, 
but the kinetics were similar in the two groups of mice   
(Fig. 2 C). These results demonstrate that Ahr is involved in 
the negative regulation of LPS responses in vivo as well.
Stat1 interacts with Ahr and regulates LPS-induced 
inflammatory responses in macrophages
We previously reported that Ahr interacts with Stat1 and in-
hibits its activation in the process of Th17 cell differentia-
tion (Kimura et al., 2008). To examine whether Ahr can bind 
with Stat1 in macrophages as it does in T cells, peritoneal 
macrophages were stimulated with LP, followed by verifica-
tion (via immunoprecipitation and Western blotting) of the 
interaction between Ahr and Stat1. The results demonstrated 
that Ahr interacted with Stat1 in macrophages after activation 
with LPS (Fig. 3 A). To verify the involvement of Stat1 in 
LPS-stimulated cytokine production, WT and Stat1 KO 
peritoneal macrophages were stimulated with LPS, and the 
protein levels of IL-6 and IL-10 were measured by means of 
ELISA. Similar to that in Ahr KO peritoneal macrophages, 
LPS-induced IL-6 production was significantly augmented in 
Stat1 KO cells, whereas IL-10 production was inhibited 
compared with that in WT cells (Fig. 3 B). We confirmed 
that Ahr was normally induced by LPS in the absence of Stat1 
(Fig. S3 A), indicating that hyperproduction of IL-6 in Stat1 
of IL-10 may cause hyperproduction of proinflammatory cy-
tokines in Ahr KO peritoneal macrophages under LPS stimu-
lation, we tested whether the addition of IL-10 to Ahr KO 
cells stimulated by LPS normalizes the overproduction of 
proinflammatory cytokine. Although IL-10 inhibited LPS-
induced IL-6 production in Ahr KO cells by 40% com-
pared with that by LPS stimulation only, its production was 
higher than that in WT cells stimulated by LPS (Fig. S2). Ad-
ditionally, we found that RAW cells were not able to pro-
duce IL-10 under LPS stimulation (unpublished data), which 
suggests that the inhibition of LPS-induced proinflammatory 
cytokines in RAW/Ahr cells is unrelated to IL-10. These   
results indicate that Ahr regulates the production of LPS-
  induced proinflammatory cytokines independently of IL-10.
Ahr-deficient mice are hyperresponsive to LPS
Because Ahr KO peritoneal macrophages showed a higher 
level of LPS-induced proinflammatory cytokine production 
than WT cells, we asked whether Ahr KO mice were more 
susceptible to LPS-induced toxicity. 6-wk-old WT and Ahr 
KO mice were injected intraperitoneally with 7.5 mg/kg of 
LPS. As shown in Fig. 2 A, all Ahr KO mice died within   
60 h of being injected, but their WT littermates did not. We 
next measured serum levels of IL-6 and TNF- in WT and 
Ahr KO mice after the LPS challenge. The serum IL-6 level 
in WT mice peaked 2 h after LPS administration, and then 
returned to the baseline level by 24 h, which is consistent 
with previously reported findings (Basu et al., 1997). In con-
trast, although serum IL-6 levels in Ahr KO mice increased 
Figure 1.  Ahr deficiency augments LPS-induced proinflammatory responses in macrophages. (A) Peritoneal macrophages were stimulated with 
LPS, CpG-ODN, and TGF- plus IL-6 for 24 h. The cells were lysed and subjected to immunoblotting (IB) analysis for the expression of Ahr and G3PDH. 
Data are from one representative of three independent experiments. (B–D) WT and Ahr KO peritoneal macrophages or RAW/Neo and RAW/Ahr cells were 
stimulated with LPS. Supernatants were collected 24 h after stimulation, and the production of IL-6, TNF-, IL-12p40, and IL-10 were measured by means 
of ELISA. Data show means ± SEM of three independent experiments (*, P < 0.05; **, P < 0.005; ***, P < 0.001).2030 AHR PARTICIPATES IN INNATE IMMUNE SYSTEM | Kimura et al.
we examined both LPS-induced IFN- production and the 
expression of SOCS-1 and SOCS-3 in WT and Ahr KO 
peritoneal macrophages stimulated with LPS. We found no 
changes in IFN- production or SOCSs expression in WT 
and Ahr KO cells after LPS stimulation (Fig. S3, B and C), 
indicating that the suppression of Stat1 activation by LPS   
in Ahr KO macrophages occurs independently of IFN-  
and SOCSs. Collectively, these findings suggest that Ahr   
may directly protect the inactivation of Stat1 in macro-
phages through interacting with it, followed by regulation of 
LPS signaling.
Ahr–Stat1 complex binds to NF-B and suppresses its 
transcriptional activity, but not its DNA-binding capacity
The production of proinflammatory cytokines such as IL-6 
and TNF- by LPS is induced via the MyD88-dependent 
NF-B pathway (Kawai et al., 1999; Beutler and Rietschel, 
2003). It has also been reported that Ahr combines with   
NF-B, and that this complex regulates several signal pathways 
(Tian et al., 1999, 2002; Vogel et al., 2007). We speculated 
that the Ahr–Stat1 complex might interact with NF-B, fol-
lowed by regulation of the NF-B pathway by the resultant 
complex. To test this hypothesis, we first examined whether 
KO peritoneal macrophages stimulated by LPS is not caused 
by the absence of Ahr.
We previously demonstrated that Ahr inhibits Stat1 acti-
vation  in  naive  T  cells  under  Th17-polarizing  conditions 
(TGF- plus IL-6; Kimura et al., 2008). In macrophages, 
however, Ahr prolonged Stat1 activation by LPS. LPS-
  induced Stat1 activation was diminished in Ahr KO macro-
phages compared with that in WT cells (Fig. 3 C). On the 
other hand, LPS-induced Stat1 activation was prolonged in 
RAW/Ahr  cells  compared  with  that  in  RAW/Neo  cells 
(Fig. 3 C). Because it has been reported that LPS-dependent 
Stat1  phosphorylation  is  mainly  dependent  on  IFN- 
(Toshchakov et al., 2002) and that SOCS proteins are impor-
tant for regulating Stat1 activation (Yoshimura et al., 2007), 
Figure 2.  Hypersensitivity of Ahr KO mice to LPS in vivo. 6-wk-old 
Ahr KO mice and littermate WT mice (n = 10 for each) were i.p. injected 
with 7.5 mg/kg of LPS. (A) Lethality was observed over 60 h after LPS 
challenge. Data are representative of two independent experiments.  
(B and C) Serum levels of IL-6 and TNF- between WT and Ahr KO mice 
were measured by ELISA at indicated time points after LPS challenge. Data 
show means ± SEM of three independent experiments (*, P < 0.05; **, P < 
0.01; ***, P < 0.001).
Figure 3.  Association between Ahr and Stat1 in macrophages.  
(A) Peritoneal macrophages were isolated from BALB/c mice and stimu-
lated by LPS for 24 h. Interaction between Ahr and Stat1 was examined by 
means of immunoprecipitation (IP) and Western blotting. Data are from 
one representative of three independent experiments. IB, immunoblot.  
(B) WT and Stat1 KO peritoneal macrophages were stimulated with LPS. 
Supernatants were collected 24 h after stimulation, and the production of 
IL-6 and IL-10 were measured by means of ELISA. Data show means ± 
SEM of three independent experiments (**, P < 0.005; ***, P < 0.001).  
(C) WT and Ahr KO peritoneal macrophages or RAW/Neo and RAW/Ahr 
cells were incubated with LPS at the indicated time points. Whole-cell 
lysates were used for immunoblotting analysis with anti–phospho- 
tyrosine Stat1, Stat1, and G3PDH antibodies (Ab). Data are from one rep-
resentative of three independent experiments.JEM VOL. 206, August 31, 2009 
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transfected with a reporter plasmid containing the promoter 
of IL-6 combined with either Ahr or a control vector. After 
treatment with LPS, luciferase activities were measured with 
the dual luciferase reporter assay system. LPS-induced activa-
tion of the IL-6 promoter was significantly suppressed in 
RAW cells overexpressing Ahr (Fig. 4 C), which suggests 
that Ahr inhibits the NF-B transcriptional activity on LPS-
induced IL-6 production. For further investigation of how 
Ahr regulates LPS-induced NF-B activation, we used the 
TransAM assay to assess NF-B DNA binding activity be-
tween RAW/Neo and RAW/Ahr cells stimulated by LPS. 
Ahr showed no significant influence on LPS-induced NF-B 
DNA binding activity between those cells (Fig. 4 D). Simi-
larly, NF-B bound to its target DNA upon LPS stimulation 
of both WT- and Ahr-KO peritoneal macrophages (Fig. 4 D). 
Ahr interacts with NF-B together with Stat1. COS7 cells 
were transiently transfected with Ahr, NF-B p50, and Stat1 
and subjected to coimmunoprecipitation analysis. As shown 
in Fig. 4 A, Ahr interacted with NF-B p50 (lane 6) and 
formed a complex together with NF-B p50 and Stat1 (lane 
5). Furthermore, to determine whether endogenous Ahr 
forms a complex together with endogenous Stat1 and NF-B 
p50, peritoneal macrophages were stimulated with LPS, fol-
lowed by verification by means of immunoprecipitation and 
Western blotting of the association of their endogenous pro-
teins. We also found that Ahr interacts with Stat1 and NF-B 
p50 endogenously in peritoneal macrophages activated by 
LPS (Fig. 4 B).
We next examined the effect of Ahr on LPS-induced ac-
tivation of the IL-6 promoter. RAW cells were transiently 
Figure 4.  Ahr inhibits LPS-induced NF-B transcriptional activity together with Stat1. (A) COS7 cells were cotransfected with Ahr, Stat1, and 
p50-Flag. After 24 h, the cells were lysed and immunoprecipitated with anti-Flag Ab, followed by detection of Ahr, Stat1, and p50 by means of Western 
blotting. Data are from one representative of three independent experiments. IP, immunoprecipitation; IB, immunoblot. (B) Peritoneal macrophages were 
stimulated with LPS for 24 h. Whole-cell lysates were immunoprecipitated with anti-p50 antibody, after which Ahr, p65, and Stat1 were detected with 
Western blotting. Data are from one representative of three independent experiments. (C) RAW cells were transiently cotransfected with luciferase re-
porter gene construct of the murine IL-6 promoter and an expression vector for Ahr (RAW/Ahr) or empty control expression vector (RAW/empty vector). 
6 h after transfection, cells were stimulated with LPS for 12 h. Luciferase assay and quantitation were performed as described in Materials and methods. 
Data show means ± SEM of three independent experiments (**, P < 0.02). (D) RAW/Neo and RAW/Ahr or WT and Ahr KO peritoneal macrophages were 
stimulated with LPS for 24 h NF-B binding activity was examined using TransAM assay. Data show means ± SEM of three independent experiments.  
(E) Peritoneal macrophages from WT and Ahr KO mice were stimulated with LPS for 4 h, and the ChIP assay was performed using anti-p50, anti-p65, anti-
Stat1, and anti-Ahr antibodies. Purified DNA fragments were amplified using primers specific for the IL-6 promoter. Data are from one representative of 
three independent experiments.2032 AHR PARTICIPATES IN INNATE IMMUNE SYSTEM | Kimura et al.
in response to LPS in combination with NF-B. Peritoneal 
macrophages from WT and Ahr KO mice were stimulated 
with LPS for 4 h, and the ChIP assay was performed using 
antibodies for detection of Ahr, Stat1, p50, and p65, and it 
was found that although p50 and p65 were recruited to the 
IL-6 promoter in response to LPS in both cells, Ahr and 
Stat1 bound to the IL-6 promoter region in WT, but not 
in Ahr KO cells (Fig. 4 E). These results indicate that Ahr, 
in combination with Stat1, regulates LPS-induced proin-
flammatory cytokine production in macrophages through 
inhibition of NF-B transcriptional activity in their pro-
moter region.
Ahr does not participate in CpG-ODN signaling
As shown in Fig. 1 A, Ahr was induced in peritoneal macro-
phages stimulated by CpG-ODN and LPS. We therefore 
asked whether Ahr regulates the CpG-ODN–TLR9 path-
way. WT and Ahr KO peritoneal macrophages were stimu-
lated with CpG-ODN, and the protein levels of IL-6 and 
IL-10 were measured by means of ELISA. Surprisingly, we 
found that Ahr deficiency had no effect on their production 
by CpG-DNA (Fig. 5 A) and that CpG-ODN–induced acti-
vation of the IL-6 promoter was similar in RAW cells with 
or without Ahr (Fig. 5 B). Thus, Ahr is not capable of regu-
lating the CpG-ODN signaling pathway despite its expres-
sion in peritoneal macrophages stimulated with CpG-ODN.
To understand why Ahr has no effect on CpG-ODN-
induced pro- and antiinflammatory cytokine production, we 
assessed the interaction between Ahr and Stat1 in LPS- or 
CpG-ODN–treated  peritoneal  macrophages.  As  shown  in 
Fig. 3 A, although Ahr interacted with Stat1 under LPS stim-
ulation, hardly any binding of Ahr with Stat1 could be de-
tected in CpG-ODN–treated cells (Fig. 5 C). However, 
CpG-ODN activated Stat1 to the same degree as did LPS 
stimulation (Fig. 5 D), indicating that the complex formation 
of Ahr with Stat1 is independent of Stat1 activation. These 
results suggest that it may be required for some natural ligand 
for Ahr to form the complex with Stat1 and that LPS may   
be able to induce some natural ligand for Ahr, but not 
CpG-ODN.
DISCUSSION
Ahr is a ligand-inducible transcription factor, which has been 
shown to regulate the expression of a variety of genes, in-
cluding those encoding for cytochrome P450 enzymes. In 
addition, Ahr activation by ligands such as dioxin has been 
linked to alterations in cell proliferation, apoptosis, tumor 
promotion, development, and reproductive functions (Puga 
et al., 2000; Shimizu et al., 2000; Bonnesen et al., 2001).   
A growing number of studies have recently detailed the various 
effects of Ahr on the immune system, especially the develop-
ment of Th17 cells (Kimura et al., 2008; Quintana et al., 
2008; Veldhoen et al., 2008). Because we found that Ahr-KO 
mice all die under conventional conditions, it was ex-
pected that Ahr might also participate in the innate immune 
system, which is capable of recognizing a wide variety of 
Cytosolic IB- is reportedly degraded upon activation of 
NF-B (Brown et al., 1993), and we also found no difference 
in IB- degradation in macrophages stimulated by LPS with 
or without Ahr (Fig. S4). These findings demonstrate that 
Ahr suppresses the NF-B transcriptional activity of the IL-6 
promoter, but not its DNA-binding capacity. It has further 
been reported that IL-6 production is required to induce 
IB via the Myd88-dependent NF-B pathway in LPS sig-
naling, followed by the association of IB with p50 and   
recruitment of the resultant complex to the IL-6 promoter 
(Yamamoto et al., 2004). We therefore examined whether 
Ahr affects IB induction by LPS and found no difference 
in its induction by LPS in RAW/Ahr and RAW/Neo cells 
(Fig. S5). This result is consistent with that illustrated in   
Fig. 4 D, which shows that Ahr does not affect the NF-B 
DNA-binding activity. These findings indicate that Ahr se-
lectively inhibits NF-B transcriptional activity in the LPS 
signaling pathway.
We further examined whether upon LPS stimulation 
the Ahr–Stat1 complex can interact with NF-B on the 
promoter region of proinflammatory cytokines and then 
suppress  LPS-induced  NF-B  transcriptional  activation 
and inflammatory cytokine production. We performed the 
chromatin immunoprecipitation (ChIP) assay to determine 
whether Ahr and Stat1 are recruited to the IL-6 promoter 
Figure 5.  Ahr has no influence in CpG-ODN signaling pathway.  
(A) WT and Ahr KO peritoneal macrophages were stimulated with  
CpG-ODN for 24 h. The production of IL-6 and IL-10 were measured by 
means of ELISA. Data show means ± SE of three independent experiments.  
(B) RAW cells were transiently cotransfected with luciferase reporter gene 
construct of the murine IL-6 promoter and an expression vector for Ahr 
(RAW/Ahr) or empty control expression vector (RAW/empty vector). 6 h 
after transfection, cells were stimulated with CpG-ODN for 12 h. Lucifer-
ase assay and quantitation were performed as described in Materials and 
methods. Data show means ± SEM of three independent experiments. 
Peritoneal macrophages were stimulated with LPS and CpG-ODN. (C) Cells 
were lysed, immunoprecipitated by Ahr, and analyzed by Western blotting 
with anti-Stat1 Ab. IP, immunoprecipitation; IB, immunoblot. (D) Whole-
cell lysates subjected to Western analysis with anti-pYStat1 antibodies. 
Data are from one representative of three independent experiments.JEM VOL. 206, August 31, 2009 
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through interacting directly with ER on the promoter   
sequences of estrogen receptor–target genes (Kanno et al., 
2008). This seems to imply that the Ahr–Stat1 complex may 
inhibit LPS-induced NF-B transcriptional activity via a co-
repressor such as Ahrr.
Two groups in addition to ours recently reported that 
Ahr participates in Th17 cell differentiation (Kimura et al., 
2008; Quintana et al., 2008; Veldhoen et al., 2008). In our 
study, we provided evidence that Ahr is involved in the   
differentiation of Th17 cells by inhibiting Stat1 activation, 
which suppresses Th17 cell differentiation, under Th17-
polarizing  conditions  (TGF-  plus  IL-6).  Stat1  activation 
was eliminated 24 h after stimulation with TGF- plus IL-6 
in WT naive T cells, whereas its activation was maintained in 
Ahr-deficient naive T cells (Kimura et al., 2008). In contrast, 
Stat1 activation by LPS was inhibited in Ahr-deficient mac-
rophages, compared with that in normal macrophages. These 
findings indicate that Stat1 activation is differentially regu-
lated by Ahr in T cells and macrophages. Ahr is known to 
perform a dual function in controlling intracellular protein 
levels, serving both as a transcriptional factor and as a ligand-
dependent E3 ubiquitin ligase (Ohtake et al., 2007). It is also 
possible that, although Ahr regulates the activation of Stat1 
through the degradation of activated Stat1 by functioning as 
a ligand-dependent E3 ubiquitin ligase in the generation of 
Th17 cells, it acts like a transcriptional factor and cooperates 
with Stat1 to regulate NF-B transcriptional activation in 
LPS-activated macrophages. Thus, the Ahr–Stat1 combina-
tion controls immune responses in different ways depending 
on the immune cell population.
The CpG-ODN–TLR9 signaling pathway and the LPS–
TLR4 signaling pathway induce proinflammatory cytokines 
such as IL-6 via MyD88-NF-B (Akira and Takeda, 2004). 
However, our findings demonstrate that Ahr is incapable of 
regulating the production of pro- and antiinflammatory cyto-
kines by CpG-ODN, although it is induced in peritoneal 
macrophages stimulated with CpG-ODN. Interestingly, Ahr 
interacted with Stat1 in the peritoneal macrophages under 
stimulation with LPS, but not with CpG-ODN, even though 
the level of Stat1 activation was the same for these two stimu-
lations, which may account for the difference between the 
LPS and CpG-ODN signaling pathways in the regulation   
by Ahr of pro- and antiinflammatory cytokine production. 
Given that Ahr forms the complex together with Stat1 and 
p50 on the IL-6 promoter region and regulates NF-B tran-
scriptional activity, Stat1 may be required for the inhibition 
of NF-B transcriptional activity by Ahr. Some natural li-
gand may be required when Ahr forms the complex with 
Stat1, followed by the regulation of NF-B.
Our preliminary data show that IL-6 suppresses LPS-
induced Ahr expression in macrophages (unpublished data). 
As seen in Fig. 1 A, the expression of Ahr in macrophages 
was inhibited by IL-6 in combination with TGF-. In this 
study, we demonstrated that Ahr performs an antiinflamma-
tory function in macrophages. It can thus be speculated that 
IL-6 may amplify proinflammatory responses in macrophages 
pathogens and rapidly inducing various antimicrobial and in-
flammatory responses. In this study, we identified an impor-
tant role of Ahr in TLR signaling, that is, Ahr combined with 
Stat1 controls LPS–TLR4–mediated pro- and antiinflamma-
tory cytokine production.
Initially, we demonstrated that TLR ligands such as LPS, 
but not IL-6 in combination with TGF-, induced Ahr ex-
pression in macrophages and that, whereas the production   
of proinflammatory cytokines such as IL-6, TNF-, and   
IL-12p40 was drastically increased upon LPS stimulation, pro-
duction of the antiinflammatory cytokine IL-10 was inhibited 
in the absence of Ahr. In addition, we found that Ahr-defi-
cient mice were highly susceptible to LPS-induced toxicity. 
The levels of serum IL-6 and TNF- in Ahr KO mice were 
higher than those in WT mice after LPS challenge. These 
findings indicate that Ahr contributes to the negative regula-
tion of the LPS signal pathway both in vivo and in vitro.
We also found that Ahr forms a complex with Stat1 and 
NF-B, which is consistent with previous findings that Ahr 
interacts with several transcriptional factors, such as Stat1 and 
NF-B (Tian et al., 1999, 2002; Vogel et al., 2007; Kimura 
et al., 2008). An important finding of our current study is that 
Stat1 deficiency, like Ahr deficiency, led to an increase in 
LPS-induced IL-6 production, but suppressed production of 
the LPS-induced antiinflammatory cytokine IL-10. How-
ever, it was previously reported that Stat1-deficient mice are 
resistant to LPS-induced shock (Karaghiosoff et al., 2003), 
which seems to conflict with our finding that Stat1-deficient 
macrophages produce more IL-6 and less IL-10 compared 
with those produced in WT cells. Stat1 contributes to the 
development  of  endotoxin  shock  through  its  central  role   
in IFN responses, which are secondarily induced by LPS 
(Karaghiosoff et al., 2003). Stat1 deficiency therefore shows 
resistance to LPS-induced shock in vivo through blocking 
LPS-induced secondary cytokine (IFN) signaling. We specu-
late that Stat1 takes part in not only LPS-induced secondary 
responses (IFN responses) in vivo but also in direct signaling 
of LPS in vitro through interacting with NF-B and Ahr;   
in the latter function Stat1 has the property to suppress   
LPS-NF-B signaling.
The findings that Ahr inhibits LPS-induced activation of 
the IL-6 promoter and interacts in combination with both 
NF-B and Stat1 on the same region of the IL-6 promoter 
suggest  that  the  Ahr–Stat1  complex  may  control  LPS-
  induced proinflammatory responses by inhibiting NF-B tran-
scriptional activity. In fact, NF-B DNA-binding activity 
was not inhibited by Ahr, which is consistent with the find-
ing that Ahr did not affect the expression of IB via the 
LPS-MyD88-dependent pathway. At present, however, the 
detailed mechanism of Ahr in suppressing NF-B transcrip-
tional activity remains poorly understood. Nuclear receptors 
in combination with coactivators and corepressors can switch 
the transcriptional activity of several transcriptional factors on 
and off, respectively. It was recently reported that Ahr repres-
sor (Ahrr), known as an Ahr negative regulator, represses   
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Inc.), respectively, and then subjected to SDS-PAGE. Whole-cell lysates and 
the immunocomplex were analyzed with Western blotting using anti-Stat1 
(BD), anti-p65 (Santa Cruz Biotechnology, Inc.), or anti-Ahr (BIOMOL 
International L.P.). COS7 cells were cotransfected with 1 µg of pEF-BOS-
Ahr, pEF-BOS-Stat1, and pEF-BOS-p50-Flag with the aid of FuGENE 6 
(Roche). Cells were lysed with lysis buffer and lysates were immunoprecipi-
tated with anti-Flag M2 (Sigma-Aldrich). Immunoprecipitated samples were 
analyzed by means of Western blotting by using anti-Ahr (BIOMOL), anti-
Stat1 (BD) and anti-p50 (Santa Cruz Biotechnology, Inc.).
Activation of Stat1. WT and Ahr KO peritoneal macrophages or RAW/
Neo and RAW/Ahr cells were incubated with 1 µg/ml LPS for the time in-
dicated, and cells were lysed with a lysis buffer. Whole-cell lysates were then 
analyzed by means of Western blotting using anti–phospho-Stat1 (Tyr701; 
Cell Signaling Technology).
Luciferase assay. RAW cells were transfected with 1 µg of the reporter 
plasmid and, in cotransfection experiments, with 0.1 µg of pRL-TK for use 
as an internal control reporter and 1 µg of pEF-BOS-Ahr or an empty vector 
(pEF-BOS). Cells were stimulated with 1 µg/ml LPS or 1 µM phosphoro-
thioate-modified CpG-ODN for 12 h and lysed with luciferase lysis reagent 
(Promega). Luciferase activity was determined with a commercial dual-lucif-
erase reporter assay system (Promega) according to the manufacturer’s in-
structions. Relative light units of Firefly luciferase activity were normalized 
with Renilla luciferase activity.
TransAM assay. RAW/Neo and RAW/Ahr cells or WT and Ahr KO 
peritoneal macrophages were stimulated with 1 µg/ml LPS for 24 h. Nuclear 
extraction was performed with a nuclear extraction kit (Active Motif). 10 µg 
of nuclear extraction protein was used for assessing the NF-B binding ac-
tivity with the NF-B (p50) TransAM Assay (Active Motif) according to the 
manufacturer’s instructions.
ChIP assay. The ChIP assay was performed essentially according to Upstate 
Biotechnology’s protocol. In brief, WT and Ahr KO peritoneal macrophages 
were stimulated with 1 µg/ml LPS for 12 h, and then fixed with formaldehyde 
for 10 min. The cells were lysed, sheared by sonication, and incubated over-
night with specific antibodies, followed by incubation with protein A-agarose 
saturated with salmon sperm DNA (Vector Laboratories). Precipitated DNAs 
were analyzed by quantitative PCR (35 cycles) using primers 5-CGATGC-
TAAACGACGTCACATTGTGCA-3  and  5-CTCCAGAGCAGAAT-
GAGCTACAGACAT-3 for the B site in the IL-6 promoter.
Statistical analysis. Student’s t test was used to analyze data for significant 
differences. Values of P < 0.05 were regarded as significant.
Online supplemental material. Fig. S1 shows that Ahr regulates LPS-
  induced production of IL-6 with or without natural ligands for Ahr in culture 
medium. Fig. S2 shows that that hypoproduction of IL-10 does not cause 
hyperproduction of proinflammatory cytokines in Ahr KO peritoneal macro-
phages under LPS stimulation. Fig. S3 shows the expression of Ahr in Stat1 KO 
peritoneal macrophages and the induction of IFN- and SOCS family mem-
bers in Ahr KO cells. Fig. S4 shows the IB- degradation in WT and Ahr KO 
macrophages stimulated by LPS. Fig. S5 shows the IB expression in RAW/
Neo and RAW/Ahr cells stimulated by LPS. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20090560/DC1.
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through inhibiting the expression of Ahr, which suppresses 
LPS-induced proinflammatory responses. In T cells, on 
the other hand, IL-6 combined with TGF- induces the   
expression of Ahr, which participates in Th17 cell differenti-
ation. IL-6 thus promotes proinflammatory responses through 
the differential regulation of Ahr expression in macrophages 
and T cells.
To summarize, we have identified and characterized a 
novel regulatory mechanism of the TLR signaling pathway in 
which Ahr in combination with Stat1 concurrently controls 
LPS-induced pro- and antiinflammatory cytokine produc-
tion. We have also provided evidence that Ahr differentially 
regulates Stat1 activation and NF-B transcriptional activity 
in T cells and macrophages, respectively. This suggests that 
Ahr may control several immune responses through the regu-
lation of transcriptional factors, such as the Stat and NF-B 
families, and be involved in several autoimmune diseases. It is 
necessary to gain an understanding of how Ahr regulates the 
immune system in various immune cells such as T cells,   
B cells, macrophages and dendritic cells. Further studies using 
each immune cell–specific Ahr conditional KO mice will   
define the functions of Ahr in immunity and several auto-
immune diseases.
MATERIALS AND METHODS
Mice. C57BL/6 WT mice were obtained from CLEA Japan, Inc. Ahr KO 
mice and Stat1 KO mice (C57BL/6 background) were provided by Y. Fujii-
Kuriyama (University of Tsukuba, Tsukuba, Japan) and T. Naka (National 
Institute of Biomedical Innovation, Osaka, Japan), respectively. All mice 
were maintained under specific pathogen-free conditions. All animal experi-
ments were performed in accordance with protocols approved by the Insti-
tutional Animal Care and Use Committees of the Graduate School of 
Frontier Bioscience, Osaka University. WT and Ahr KO mice were injected 
i.p. with the indicated amounts of LPS (Escherichia coli; Sigma-Aldrich) for 
the indicated periods of time.
Cell culture and reagents. Peritoneal macrophages were prepared as pre-
viously described (Kimura et al., 2005). The thioglycolate-elicited peritoneal 
macrophages and a mouse macrophage cell line (RAW cells) were cultured 
in RPMI 1640 with 10% FCS, 100 µg/ml streptomycin, and 100 U/ml 
penicillin G. RAW cells were stably transfected with Ahr cDNAs (donated 
by Y. Fujii-Kuriyama). Stably transfected RAW mutant lines (RAW/Neo, 
RAW/Ahr) were maintained in the presence of 500 µg/ml G418. COS7 
cells were cultured in DME with 10% FCS, 100 µg/ml streptomycin, and 
100 U/ml penicillin G. We stimulated the cells with 1 µg/ml LPS (E. coli; 
Sigma-Aldrich), 1 µM phosphorothioate-modified CpG-ODN, 20 ng/ml 
mouse IL-6 and 2 ng/ml human TGF-1 (both from R&D Systems) for the 
indicated periods of time.
Cytokine ELISA. The cells were stimulated with 1 µg/ml LPS (E. coli; 
Sigma-Aldrich) and 1 µM phosphorothioate-modified CpG-ODN for 24 h. 
Mouse IL-6, TNF-, IL-12p40, and IL-10 from either the supernatants or 
the serum were measured by means of ELISA according to the manufactur-
er’s instructions (R&D Systems).
Immunoprecipitation and Western blotting. Peritoneal macrophages 
were cultured with 1 µg/ml LPS or 1 µM phosphorothioate-modified CpG-
ODN for 24 h and then lysed with a lysis buffer (1% NP-40, 20 mM Tris-
HCl, ph 7.5, 150 mM NaCl, 10 mM Na2VO4, 0.5 mM DTT, and 1/100 
protease inhibitor cocktail). Ahr and p50 were immunoprecipitated with 
anti-Ahr (BIOMOL International) and anti-p50 (Santa Cruz Biotechnology, JEM VOL. 206, August 31, 2009 
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